Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 5,149.00 | 5,035.41 | 5,051.44 | 4,132.55 | 3,660.27 |
| Expenses | |||||
| Material consumed | 1,922.43 | 1,758.35 | 1,528.06 | 1,273.97 | 1,177.48 |
| Manufacturing expenses | 182.21 | 120.50 | 109.79 | 97.43 | 88.44 |
| Personnel expenses | 1,094.82 | 1,062.30 | 948.27 | 806.37 | 684.45 |
| Selling expenses | - | - | - | - | 342.47 |
| Adminstrative expenses | 1,285.19 | 1,185.46 | 893.09 | 751.88 | 488.76 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 4,484.65 | 4,126.61 | 3,479.21 | 2,929.65 | 2,781.60 |
| Operating profit | 664.35 | 908.80 | 1,572.23 | 1,202.90 | 878.67 |
| Other recurring income | 3.54 | 51.14 | 9.73 | 134.75 | 6.42 |
| Adjusted PBDIT | 667.89 | 959.94 | 1,581.96 | 1,337.65 | 885.09 |
| Financial expenses | 49.00 | 17.02 | 12.77 | 25.19 | 14.87 |
| Depreciation | 272.95 | 284.92 | 152.60 | 135.67 | 105.59 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 345.94 | 658.00 | 1,416.59 | 1,176.79 | 764.63 |
| Tax charges | -0.79 | 114.45 | 241.20 | 197.39 | 153.42 |
| Adjusted PAT | 346.73 | 543.55 | 1,175.39 | 979.40 | 611.21 |
| Non recurring items | - | - | -0.88 | -19.33 | -1.90 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 346.73 | 543.55 | 1,174.51 | 960.07 | 609.31 |
| Earnigs before appropriation | 2,979.61 | 2,908.08 | 2,863.44 | 2,256.56 | 1,529.07 |
| Equity dividend | 196.56 | 275.19 | - | 258.43 | 59.91 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 33.77 | 15.50 |
| Retained earnings | 2,783.05 | 2,632.89 | 2,863.44 | 1,964.36 | 1,453.66 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis